Stay updated on Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial

Sign up to get notified when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.0%
    Check dated 2025-01-19T22:43:11.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.1%
    Check dated 2025-01-12T18:13:24.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The European Myeloma Network has added new results related to Velcade, including updated definitions and metrics for progression-free survival (PFS), overall response rates (ORR), and MRD negativity rates, with a maximum follow-up time of 54.41 months, while previous entries regarding post-consolidation MRD negativity and various timelines for response assessments have been removed.
    Difference
    28%
    Check dated 2024-12-29T07:49:03.000Z thumbnail image
  5. Check
    35 days ago
    No Change Detected
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.0%
    Check dated 2024-12-14T22:43:42.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.
    Difference
    1%
    Check dated 2024-12-07T16:17:53.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Several key medical and genetic resource links related to multiple myeloma and associated treatments have been removed, indicating a significant reduction in available information on this topic.
    Difference
    3%
    Check dated 2024-11-23T04:41:03.000Z thumbnail image

Stay in the know with updates to Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.